Multiple Myeloma and Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Multiple Myeloma and Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial assessing donor stem cell transplant in patients with previously treated leukemia, lymphoma, or multiple myeloma; stu…
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant [NA]
Clinical trial update on donor lymphocyte infusion for patients with recurrent or persistent hematologic cancer after donor stem cell transp…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Phase 3]
Phase 3 trial comparing darbepoetin alfa with epoetin alfa for treating anemia in patients undergoing chemotherapy for cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial [Phase 3]
Phase 3 clinical trial update focusing on personalized or basic information to aid decision-making for participating in a trial.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Treatment for Chronic Pain in Patients With Advanced Cancer [Phase 3]
Phase 3 clinical trial update for a treatment addressing chronic pain in patients with advanced cancer; status indicates completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and Umbilical Cord Blood Transplantation for hematologic cancers complete…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial investigating mycophenolate mofetil, tacrolimus, daclizumab, and donor peripheral stem cell transplantation for hemat…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 4]
Phase 4 clinical trial update on bone marrow transplantation for hematologic cancers, including conditions such as anemia and graft-versus-h…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating total-body irradiation with fludarabine and peripheral stem cell transplantation in patients with hematologic cance…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer [Phase 2]
Phase 2 trial update on a combination chemotherapy, bone marrow transplant, and post-transplant cyclophosphamide regimen for hematologic can…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating busulfan, cyclophosphamide, and antithymocyte globulin followed by stem cell transplant for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating busulfan, fludarabine, and total-body irradiation as conditioning for donor stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial assessing donor peripheral stem cell transplant with fludarabine and busulfan in hematologic cancers has completed; results po…
-
CLINICAL_TRIALS safety_alert · 2017-04-17Clinical Trial Update: Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Clinical trial update reports methemoglobinemia risk in young patients with hematologic cancers or aplastic anemia treated with dapsone in a…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
This clinical trial update notes the termination of a study examining natural killer cells in bone marrow and blood from patients with and w…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation for patients undergoing donor b…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant [NA]
A completed clinical trial evaluated adding aprepitant to granisetron and dexamethasone to prevent nausea and vomiting in patients receiving…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [Phase 1]
This document provides a Phase 1 clinical trial update on using Interleukin-12 to treat various hematologic cancers and solid tumors; the st…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer [Phase 2]
This Phase 2 trial tested sirolimus, tacrolimus, and antithymocyte globulin for preventing graft-versus-host disease in patients undergoing …
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer [Phase 3]
A Phase 3 clinical trial evaluates epoetin alfa or epoetin beta, with or without iron infusion, for treating anemia in cancer patients. The …
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: SU006668 in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on the investigational drug SU006668 being studied in patients with advanced solid tumors, including breast cancer and colore…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial evaluating sirolimus, tacrolimus, thymoglobulin, and rituximab as graft-versus-host-disease prophylaxis in haploidentical and …